McCullough Robertson’s Equity Capital Markets team has successfully advised leading Australian AI technology company, BrainChip Holdings Limited (ASX: BRN) in raising additional funds up to A$37 million to support the continued commercialisation of its Akida™ neuromorphic technology platform and the development of its expanding product portfolio of next-generation edge AI products.

The capital raise was facilitated via a fully underwritten A$35 million institutional placement to professional and sophisticated investors, together with a non-underwritten Share Purchase Plan to raise up to A$2 million from eligible shareholders in Australia and New Zealand.

A worldwide leader in edge AI on-chip processing and learning, BrainChip’s first-to-market neuromorphic processor, Akida™, mimics the human brain to analyse only essential sensor inputs at the point of acquisition, processing data with unparalleled efficiency, precision, and economy of energy.

McCullough Robertson has acted for BrainChip Holdings on a number of successful capital raisings since 2020 and is pleased to continue supporting the growth of the company’s operations, and the development of innovative neuromorphic computing product development.